We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why CNO Financial Shares Are Attracting Prudent Investors Now
Read MoreHide Full Article
Key Takeaways
CNO delivered its 16th straight quarter of sales growth, with NAP up 6.5% year over year.
CNO saw Medicare Supplement NAP jump 52% and Worksite NAP rise 29.4% in Q2 2026.
CNO raised 2026 operating EPS guidance to $4.60-$4.80 from $4.25-$4.45.
CNO Financial Group, Inc. (CNO - Free Report) is well-poised for growth, driven by strong collected premiums from annuity, life and health products, and rising new annualized premiums. A diversified product portfolio, strategic acquisitions, technological advancements and improved insurance policy income drive further momentum. In the year-to-date period, shares of CNO have risen 28.6%, outperforming the industry’s growth of 5.3%.
CNO — with a market cap of $5.1 billion — operates throughout the United States to develop, administer and market annuity, supplemental health and individual life insurance and other insurance products. Its forward 12-month P/E ratio of 11.15X is higher than the industry average of 9.35X.
Courtesy of solid prospects, CNO currently carries a Zacks Rank #2 (Buy).
Let’s delve deeper.
Where Do CNO’s Estimates Stand?
The Zacks Consensus Estimate for CNO Financial’s 2026 earnings is pegged at $4.74 per share. The consensus mark for revenues is pegged at $4 billion for 2026. Furthermore, it beat earnings estimates in each of the past four quarters, with an average surprise of 23.2%.
CNO Financial Group, Inc. Price, Consensus and EPS Surprise
CNO Financial’s growth continues to be supported by its focus on middle-income consumers and its captive-agent distribution model. The company delivered its 16th consecutive quarter of sales growth in the second quarter of 2026, with total new annualized premiums rising 6.5% year over year. The model is helping CNO maintain consistent sales momentum while expanding its customer relationships across health, life and retirement products. The total collected premiums advanced 3.6% year over year to $1.2 billion, along with 4.5% growth in the insurance policy income.
The Consumer division remains an important growth engine, particularly as demand shifts toward Medicare Supplement and retirement-income products. Medicare Supplement NAP jumped 52% in the second quarter of 2026, while total Medicare policies sold increased 12%.
CNO is also leaning into its Worksite business, where growth is being driven by geographic expansion, deeper penetration of existing markets and continued investment in its career-agent channel. Worksite NAP increased 29.4% in the quarter, while NAP from new clients rose 84%. The optimized career agency generated roughly 90% of Worksite insurance sales, prompting CNO to continue investing in the channel as it expands its reach among small and midsized businesses.
Technology and distribution efficiency are additional areas of focus. CNO is progressing with its three-year TechMod initiative to modernize parts of its technology infrastructure while shifting its direct-to-consumer life marketing mix toward web, digital and third-party channels. It is also focused on improving cost efficiency, with its second-quarter expense ratio at 18.4%, improved from 19% a year earlier, reflecting continued progress in managing expenses. Meanwhile, the company raised its 2026 operating EPS guidance to $4.60-$4.80 from the previously guided range of $4.25-$4.45.
CNO has also demonstrated a strong commitment to shareholder returns through consistent capital distribution. In second-quarter 2026, the company repurchased $60 million worth of shares and paid $16.8 million in dividends.
Risks for CNO Stock
There are some factors, however, that investors should keep a careful eye on.
CNO Financial’s balance sheet reflects a relatively high level of leverage. At the end of second-quarter 2026, its long-term debt-to-capital stood at 62.3%, more than double the industry average of 28.5%. Unrestricted cash and cash equivalents were $1.3 billion at the end of the quarter, while long-term debt amounted to $4.3 billion.
The Zacks Consensus Estimate for Hippo Holdings’ current-year earnings is pinned at $2.46 per share and has witnessed two upward revisions in the past 30 days against no movement in the opposite direction. HIPO beat earnings estimates in each of the trailing four quarters, with the average surprise being 521.8%. The consensus estimate for current-year revenues is pegged at $581.9 million, implying 24.2% year-over-year growth.
The Zacks Consensus Estimate for Slide Insurance Holdings’ current-year earnings is pinned at $3.91 per share and has witnessed two upward revisions in the past 30 days against one movement in the opposite direction. SLDE beat earnings estimates in each of the trailing four quarters, with the average surprise being 36.9%. The consensus estimate for current-year revenues is pegged at $1.5 billion, implying 33% year-over-year growth.
The Zacks Consensus Estimate for Hanover Insurance Group’s current-year earnings is pinned at $20.15 per share and has witnessed two upward revisions in the past seven days against no movement in the opposite direction. THG beat earnings estimates in each of the trailing four quarters, with the average surprise being 27.3%. The consensus estimate for current-year revenues is pegged at $7 billion, implying 4.6% year-over-year growth.
View the Zacks #1 Rank List
Image: Shutterstock
Here's Why CNO Financial Shares Are Attracting Prudent Investors Now
Key Takeaways
CNO Financial Group, Inc. (CNO - Free Report) is well-poised for growth, driven by strong collected premiums from annuity, life and health products, and rising new annualized premiums. A diversified product portfolio, strategic acquisitions, technological advancements and improved insurance policy income drive further momentum. In the year-to-date period, shares of CNO have risen 28.6%, outperforming the industry’s growth of 5.3%.
CNO — with a market cap of $5.1 billion — operates throughout the United States to develop, administer and market annuity, supplemental health and individual life insurance and other insurance products. Its forward 12-month P/E ratio of 11.15X is higher than the industry average of 9.35X.
Courtesy of solid prospects, CNO currently carries a Zacks Rank #2 (Buy).
Let’s delve deeper.
Where Do CNO’s Estimates Stand?
The Zacks Consensus Estimate for CNO Financial’s 2026 earnings is pegged at $4.74 per share. The consensus mark for revenues is pegged at $4 billion for 2026. Furthermore, it beat earnings estimates in each of the past four quarters, with an average surprise of 23.2%.
CNO Financial Group, Inc. Price, Consensus and EPS Surprise
CNO Financial Group, Inc. price-consensus-eps-surprise-chart | CNO Financial Group, Inc. Quote
CNO’s Growth Drivers
CNO Financial’s growth continues to be supported by its focus on middle-income consumers and its captive-agent distribution model. The company delivered its 16th consecutive quarter of sales growth in the second quarter of 2026, with total new annualized premiums rising 6.5% year over year. The model is helping CNO maintain consistent sales momentum while expanding its customer relationships across health, life and retirement products. The total collected premiums advanced 3.6% year over year to $1.2 billion, along with 4.5% growth in the insurance policy income.
The Consumer division remains an important growth engine, particularly as demand shifts toward Medicare Supplement and retirement-income products. Medicare Supplement NAP jumped 52% in the second quarter of 2026, while total Medicare policies sold increased 12%.
CNO is also leaning into its Worksite business, where growth is being driven by geographic expansion, deeper penetration of existing markets and continued investment in its career-agent channel. Worksite NAP increased 29.4% in the quarter, while NAP from new clients rose 84%. The optimized career agency generated roughly 90% of Worksite insurance sales, prompting CNO to continue investing in the channel as it expands its reach among small and midsized businesses.
Technology and distribution efficiency are additional areas of focus. CNO is progressing with its three-year TechMod initiative to modernize parts of its technology infrastructure while shifting its direct-to-consumer life marketing mix toward web, digital and third-party channels. It is also focused on improving cost efficiency, with its second-quarter expense ratio at 18.4%, improved from 19% a year earlier, reflecting continued progress in managing expenses. Meanwhile, the company raised its 2026 operating EPS guidance to $4.60-$4.80 from the previously guided range of $4.25-$4.45.
CNO has also demonstrated a strong commitment to shareholder returns through consistent capital distribution. In second-quarter 2026, the company repurchased $60 million worth of shares and paid $16.8 million in dividends.
Risks for CNO Stock
There are some factors, however, that investors should keep a careful eye on.
CNO Financial’s balance sheet reflects a relatively high level of leverage. At the end of second-quarter 2026, its long-term debt-to-capital stood at 62.3%, more than double the industry average of 28.5%. Unrestricted cash and cash equivalents were $1.3 billion at the end of the quarter, while long-term debt amounted to $4.3 billion.
Other Top-Ranked Players
Some other top-ranked stocks in the insurance space are Hippo Holdings Inc. (HIPO - Free Report) , Slide Insurance Holdings, Inc. (SLDE - Free Report) and The Hanover Insurance Group, Inc. (THG - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Hippo Holdings’ current-year earnings is pinned at $2.46 per share and has witnessed two upward revisions in the past 30 days against no movement in the opposite direction. HIPO beat earnings estimates in each of the trailing four quarters, with the average surprise being 521.8%. The consensus estimate for current-year revenues is pegged at $581.9 million, implying 24.2% year-over-year growth.
The Zacks Consensus Estimate for Slide Insurance Holdings’ current-year earnings is pinned at $3.91 per share and has witnessed two upward revisions in the past 30 days against one movement in the opposite direction. SLDE beat earnings estimates in each of the trailing four quarters, with the average surprise being 36.9%. The consensus estimate for current-year revenues is pegged at $1.5 billion, implying 33% year-over-year growth.
The Zacks Consensus Estimate for Hanover Insurance Group’s current-year earnings is pinned at $20.15 per share and has witnessed two upward revisions in the past seven days against no movement in the opposite direction. THG beat earnings estimates in each of the trailing four quarters, with the average surprise being 27.3%. The consensus estimate for current-year revenues is pegged at $7 billion, implying 4.6% year-over-year growth.